CorTec receives FDA Breakthrough for Brain Interchange in stroke recovery

CorTec/Brain Interchange

CorTec announced FDA Breakthrough designation for Brain Interchange for stroke rehabilitation. The designation covers direct cortical electrical stimulation to support motor recovery in chronic stroke patients.

• FDA Breakthrough designation for stroke motor rehabilitation.
• First BCI worldwide designated for stroke motor recovery.
• Based on clinical trial showing motor recovery in implanted patients.
• Expedited FDA review path enabled for commercialization.